trū® Chitosan Files Patent on New USP Inhalant Product
Summary by abc12/WJRT
26 Articles
26 Articles

+25 Reposted by 25 other sources
trū® Chitosan Files Patent on New USP Inhalant Product
BALATON, Minn., July 15, 2025 /PRNewswire/ -- trū® Chitosan, a brand of iterro Life Sciences, announced the introduction of trū Chitosan USP Inhalant—the first commercially available chitosan qualified for inhaled drug delivery, based on USP and USP 232 standards.
·Flint, United States
Read Full ArticleCoverage Details
Total News Sources26
Leaning Left1Leaning Right0Center14Last UpdatedBias Distribution93% Center
Bias Distribution
- 93% of the sources are Center
93% Center
C 93%
Factuality
To view factuality data please Upgrade to Premium